Our research finds that Life Sciences CEOs are confident in industry growth fueled by innovation, technological advancement, and operational efficiency. There is a strong appetite for mergers and acquisitions, substantial investments in AI and digitalisation, and a critical need to empower the workforce to navigate rapid change. While sustainability and ESG remain high on the agenda for Life Sciences organisations globally, there are shifting priorities across regions.
Key findings
Organisations that have already adapted their growth strategies due to interrelated challenges
Life sciences: 80%
Cross sector average: 72%
86%
have a moderate-to-high appetite for M&A over the next three years
25%
integrate the costs and ROI of sustainability initiatives into every major capital investment
73%
expect most corporate staff to be working in hybrid models within three years
Why download the report?
By downloading the 2025 Life Sciences CEO Outlook, you’ll unlock unique perspectives on:
- Industry growth prospects and drivers, M&A appetite, and operational challenges
- AI and other capabilities investment
- Workforce challenges and transformation
- Evolution of ESG strategies
Enhance your strategic planning with expert analysis and actionable insights.
Connect with us
- Find office locations kpmg.findOfficeLocations
- kpmg.emailUs
- Social media @ KPMG kpmg.socialMedia